Enhertu Price in India- Alleviare India



Use of Enhertu

ENHERTU is a prescription medication used to treat certain types of cancer. Specifically, it is used to treat HER2-positive breast cancer that has spread to other parts of the body and has not responded to other treatments.

ENHERTU is a type of medication called an antibody-drug conjugate (ADC). ADCs are made up of an antibody that is designed to target a specific protein on cancer cells, and a chemotherapy drug that is attached to the antibody. Once the ADC attaches to the cancer cells, the chemotherapy drug is released and destroys the cancer cells.

ENHERTU is given as an intravenous (IV) infusion over the course of 30 minutes. The dosage and frequency of the medication may vary depending on the patient's individual condition and response to treatment.

It is important to note that ENHERTU may cause side effects, some of which can be serious. Common side effects may include nausea, vomiting, fatigue, hair loss, and decreased appetite. Patients should discuss any concerns or questions about ENHERTU with their healthcare provider.

How to Buy Enhertu in India?

Enhertu suppliers in India. Allevaire India New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

Enhertu Price In India

The order for Enhertu will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Please contact +91 9818274099 for ENHERTU price in India.

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.



Comments

Post a Comment

Popular posts from this blog

Polivy 140mg Injection: Treatment for Relapsed or Refractory DLBCL

Image
  Medical advancements have revolutionized cancer treatment, providing hope to patients facing challenging conditions. Polivy 140mg injection is a groundbreaking medication used in the management of relapsed or refractory diffuse large B-cell lymphoma (DLBCL). In this blog post, we will explore the uses and treatment aspects of Polivy 140mg injection, as well as shed light on where one can obtain this medication. Understanding Polivy 140mg Injection:  Polivy (polatuzumab vedotin) 140mg injection is an FDA-approved targeted therapy specifically designed for adult patients with relapsed or refractory DLBCL who have undergone at least two prior therapies. DLBCL is a form of non-Hodgkin's lymphoma characterized by the rapid growth of cancerous B-cells within the lymphatic system. Treatment with Polivy 140mg Injection:  Polivy 140mg injection is administered in combination with bendamustine and rituximab, forming the BR/Polivy regimen. This approach aims to enhance treatment ...
Read more

What Patients Should Know about Early Access Programs- AlleviareIndia

Image
  Introduction: In the world of medical research and development, new treatments, drugs, and therapies are constantly being developed to address various health conditions. However, the journey from initial development to final approval by regulatory authorities can be a lengthy process, leaving many patients eagerly awaiting access to potentially life-saving treatments. This is where Early Access Programs (EAPs) come into play. In this article, we will explore what patients should consider when participating in an Early Access Program. Understand the Purpose and Eligibility Criteria: Before considering participation in an Early Access Program, it's important to understand its purpose. EAPs are designed to provide access to investigational treatments for patients who have exhausted all other available options and have a serious or life-threatening condition. Familiarize yourself with the eligibility criteria to determine if you meet the necessary requirements. Discuss with ...
Read more

Facts of Pangraf Tacrolimus Capsules 0.5mg

Image
Pangraf Tacrolimus Capsules 0.5mg is a medication used in the management of various autoimmune diseases, including but not limited to psoriasis, rheumatoid arthritis, and ulcerative colitis. Tacrolimus is a calcineurin inhibitor, which works by blocking the production of certain substances that trigger the immune system to attack healthy tissues. As a result, it helps to suppress the inflammation and prevent the damage caused by autoimmune diseases. Pangraf is manufactured by Panacea Biotec Limited, an Indian pharmaceutical company. It is available in the form of capsules, with a dose of 0.5mg. The medication is prescribed by a healthcare professional and should be taken under their supervision. Here are some important facts about Pangraf Tacrolimus Capsules 0.5mg: Uses Pangraf Tacrolimus Capsules 0.5mg is used to manage autoimmune diseases, such as: Psoriasis: a skin condition characterized by red, scaly patches on the skin Rheumatoid arthritis: a chronic autoimmune disease that cause...
Read more